Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF‐β receptor activation

Embryo implantation requires extensive angiogenesis at the maternal‐fetal interface. Hyperglycosylated human chorionic gonadotropin (hCG‐H), a trophoblast invasive signal produced by extravillous cytotrophoblasts and by choriocarcinoma, was evaluated for its angiogenic role. hCG‐H was purified by HPLC from choriocarcinoma supernatant, and the glycosylation pattern was determined by 2D gel analysis. Angiogenesis models used were aortic ring assay with wild‐type and LHCGR‐knockout mice, endothelial and mural cell proliferation, and migration assays. The TGF‐β signaling pathway was studied by coimmunoprecipitation, competitive binding, TGF‐β reporter gene assays, and Smad immunoblotting. hCG‐H displayed a potent angiogenic effect [3.2‐fold increase of number of vessel intersections in wild‐type aortic rings (11.406 to 36.964)]. hCG‐H‐induced angiostimulation was independent of the classic hCG signaling pathway since it persisted in LHCGR‐knockout mice [4.73‐fold increase of number of vessel intersections (10.826 to 51.288)]. Using TGF‐β signaling inhibitors, Tβ‐RII was identified as the hCG‐H receptor responsible for its angiogenic switch. hCG‐H exposure enhanced phosphorylation of Smad 2 in endothelial and mural cells and genomic activation of Smad‐responsive elements. Interaction between hCG‐H and Tβ‐RII was demonstrated by coimmunoprecipitation and binding competition with 125I‐TGF‐β. This new paracrine interaction between trophoblast and endothelial cells through the hCG‐H and the TGF‐β receptor complex plays a key role in angiogenesis associated with placental development and tumorigenesis.—Berndt, S., Blacher, S., Munaut, C., Detilleux, J., Perrier d'Hauterive, S., Huhtaniemi, I., Evain‐Brion, D., Noël, A., Fournier, T., Foidart, J.‐M. Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF‐β receptor activation. FASEB J. 27, 1309–1321 (2013). www.fasebj.org

[1]  L. Cole,et al.  Hyperglycosylated hCG, hCGβ and Hyperglycosylated hCGβ: Interchangeable cancer promoters , 2012, Molecular and Cellular Endocrinology.

[2]  M. Goumans,et al.  Controlling angiogenesis by two unique TGF-β type I receptor signaling pathways. , 2011, Histology and histopathology.

[3]  P. Delves,et al.  Does hCG or hCGβ play a role in cancer cell biology? , 2010, Molecular and Cellular Endocrinology.

[4]  R. Iles,et al.  Gonadotropins and gonadotropin receptors—Evolutional genetics, signalling mechanisms, extra gonadal function and roles in oncogenesis , 2010, Molecular and Cellular Endocrinology.

[5]  J. Guibourdenche,et al.  Hyperglycosylated hCG is a marker of early human trophoblast invasion. , 2010, The Journal of clinical endocrinology and metabolism.

[6]  L. Cole Biological functions of hCG and hCG-related molecules , 2010, Reproductive biology and endocrinology : RB&E.

[7]  L. Cole,et al.  Hyperglycosylated hCG, a review. , 2010, Placenta.

[8]  H. Verspaget,et al.  Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. , 2010, Cancer research.

[9]  J. Foidart,et al.  Chorionic gonadotropin stimulation of angiogenesis and pericyte recruitment. , 2009, The Journal of clinical endocrinology and metabolism.

[10]  L. Cole,et al.  Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters. , 2008, The Journal of reproductive medicine.

[11]  L. Cole,et al.  Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. , 2008, Fertility and sterility.

[12]  N. Bersinger,et al.  Serum Hyperglycosylated Human Chorionic Gonadotropin to Predict the Gestational Outcome in in vitro Fertilization/Intracytoplasmic Sperm Injection Pregnancies , 2008, Fetal Diagnosis and Therapy.

[13]  I. Laurendeau,et al.  Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma. , 2007, Endocrinology.

[14]  I. Laurendeau,et al.  Human chorionic gonadotropin expression in human trophoblasts from early placenta: comparative study between villous and extravillous trophoblastic cells. , 2007, Placenta.

[15]  T. Kakuma,et al.  Hyperglycosylated HCG expression in pregnancy: Cellular origin and clinical applications , 2007, Molecular and Cellular Endocrinology.

[16]  J. Foidart,et al.  Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  L. Cole,et al.  Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. , 2006, The Journal of reproductive medicine.

[18]  L. Cole,et al.  Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG. , 2006, Gynecologic oncology.

[19]  L. Cole,et al.  Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. , 2006, Gynecologic oncology.

[20]  T. Libermann,et al.  Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.

[21]  C. White,et al.  Cytokines, chemokines and growth factors in endometrium related to implantation. , 2005, Human reproduction update.

[22]  T. Maruo,et al.  Transfection of antisense chorionic gonadotropin beta gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. , 2005, The Journal of clinical endocrinology and metabolism.

[23]  M. Goumans,et al.  Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction , 2004, The EMBO journal.

[24]  T M Mayhew,et al.  Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. , 2004, Placenta.

[25]  T M Mayhew,et al.  Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. , 2004, Placenta.

[26]  K. Münstedt,et al.  Angiogenesis and vasculogenesis in pregnancy. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[27]  K. Preissner,et al.  Characterization of human chorionic gonadotropin as a novel angiogenic factor. , 2002, The Journal of clinical endocrinology and metabolism.

[28]  S. Robertson,et al.  Defining the actions of transforming growth factor beta in reproduction , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[29]  M. Maio,et al.  Endoglin: An accessory component of the TGF‐β‐binding receptor‐complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies , 2001, Journal of cellular physiology.

[30]  M. Diamond,et al.  Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line. , 2000, Placenta.

[31]  S. Mathieu,et al.  The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation , 2000, British Journal of Cancer.

[32]  M. Goumans,et al.  Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. , 2000, The International journal of developmental biology.

[33]  M. Goumans,et al.  Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. , 1999, Development.

[34]  K. McCrae,et al.  SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasivess and resistance to anti‐invasive action of TGFβ , 1998, International journal of cancer.

[35]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[36]  L. Cole,et al.  Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. , 1997, Clinical chemistry.

[37]  S. Lye,et al.  Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. , 1997, Endocrinology.

[38]  M. Pepper,et al.  Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. , 1997, Cytokine & growth factor reviews.

[39]  G. Owens,et al.  Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. , 1996, Developmental biology.

[40]  R. Berkowitz,et al.  Gestational trophoblastic disease , 1995, Cancer.

[41]  G. Owens,et al.  Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.

[42]  J. Irving,et al.  Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. , 1995, Experimental cell research.

[43]  J. Spinnato,et al.  Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries. , 1994, The Journal of clinical endocrinology and metabolism.

[44]  D. C. Harris,et al.  Crystal structure of human chorionic gonadotropin , 1994, Nature.

[45]  W A Hendrickson,et al.  Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein. , 1994, Structure.

[46]  H. Kliman,et al.  Transforming growth factor-beta stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivo. , 1994, The Journal of clinical endocrinology and metabolism.

[47]  J. Környei,et al.  Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. , 1993, Biology of reproduction.

[48]  M. Kan,et al.  Bifunctional effects of transforming growth factor-β (TGF-β) on endothelial cell growth correlate with phenotypes of TGF-β binding sites , 1990 .

[49]  L. Cole HCG variants, the growth factors which drive human malignancies. , 2012, American journal of cancer research.

[50]  I. Laurendeau,et al.  Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma. , 2007, Endocrinology.

[51]  L. Cole,et al.  Hyperglycosylated hCG. , 2007, Placenta.

[52]  Jean-Michel Foidart,et al.  Improved quantification of angiogenesis in the rat aortic ring assay , 2004, Angiogenesis.

[53]  Peter Berger,et al.  Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. , 2003, Clinical chemistry.

[54]  H. M. Beier,et al.  Embryo-maternal signalling: how the embryo starts talking to its mother to accomplish implantation. , 2003, Reproductive biomedicine online.

[55]  M. Poutanen,et al.  Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. , 2001, Molecular endocrinology.

[56]  M. Kan,et al.  Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites. , 1990, Experimental cell research.

[57]  M. Ascoli Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. , 1981, Endocrinology.